Authors: Mellman, TA Miller, AL Weissman, EM Crismon, ML Essock, SM Marder, SR

Citation: Ta. Mellman et al., Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms, PSYCH SERV, 52(5), 2001, pp. 619-625

Authors: Drake, RE Essock, SM Shaner, A Carey, RB Minkoff, K Kola, L Lynde, D Osher, FC Clark, RE Rickards, L

Citation: Re. Drake et al., Implementing dual diagnosis services for clients with severe mental illness, PSYCH SERV, 52(4), 2001, pp. 469-476

Authors: Mueser, KT Essock, SM Drake, RE Wolfe, RS Frisman, L

Citation: Kt. Mueser et al., Rural and urban differences in patients with a dual diagnosis, SCHIZOPHR R, 48(1), 2001, pp. 93-107

Authors: Rosenberg, SD Goodman, LA Osher, FC Swartz, MS Essock, SM Butterfield, MI Constantine, NT Wolford, GL Salyers, MP

Citation: Sd. Rosenberg et al., Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness, AM J PUB HE, 91(1), 2001, pp. 31-37

Authors: Jackson, CT Fein, D Essock, SM Mueser, KT

Citation: Ct. Jackson et al., The effects of cognitive impairment and substance abuse on psychiatric hospitalizations, COMM MENT H, 37(4), 2001, pp. 303-312

Authors: Essock, SM Frisman, LK Covell, NH Hargreaves, WA

Citation: Sm. Essock et al., Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals, ARCH G PSYC, 57(10), 2000, pp. 987-994